Find, compare & contact
Zafirlukast
API Manufacturers & Suppliers
Canada
United States
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Producer
+ 0
All certificates
Follow us
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 21,650
Diverse portfolio of 180+APIs
1754+ DMF across global markets
1100+ patents filed, and more than 70 own patents granted
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Zafirlukast API 107753-78-6?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Zafirlukast. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Zafirlukast
- Synonyms:
- Accolate
- Cas Number:
- 107753-78-6
- DrugBank number:
- DB00549
- Unique Ingredient Identifier:
- XZ629S5L50
About Zafirlukast
It's time for some technical information for the ones who understand chemistry: Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid and/or long-acting bronchodilator. It is available as a tablet and is usually dosed twice daily. Another leukotriene receptor antagonist is montelukast (Singulair), which is usually taken just once daily. Zafirlukast blocks the action of the cysteinyl leukotrienes on the CysLT1 receptors, thus reducing constriction of the airways, build-up of mucus in the lungs and inflammation of the breathing passages.
Check who is selling Zafirlukast in the overview above.
Zafirlukast is a type of Leukotriene antagonists
Leukotriene antagonists, a subcategory of pharmaceutical active pharmaceutical ingredients (APIs), are widely used in the treatment of inflammatory conditions, particularly in respiratory disorders such as asthma. These antagonists work by inhibiting the action of leukotrienes, which are inflammatory mediators released by immune cells.
Leukotrienes play a crucial role in promoting inflammation, bronchoconstriction, and mucus production in the airways. By targeting and blocking the receptors for leukotrienes, antagonists can effectively reduce the inflammatory response and alleviate symptoms associated with asthma and other respiratory conditions.
Montelukast, zafirlukast, and pranlukast are among the most commonly prescribed leukotriene antagonists. These APIs are typically formulated into oral tablets or granules for ease of administration. They are generally well-tolerated and exhibit a favorable safety profile.
Leukotriene antagonists are often used as part of a comprehensive treatment plan for asthma management, either as a monotherapy or in combination with other medications like inhaled corticosteroids. They provide a valuable alternative for patients who may have difficulty using inhalers or require additional control of their symptoms.
In conclusion, leukotriene antagonists are an important class of pharmaceutical APIs used in the treatment of inflammatory conditions, particularly asthma. By inhibiting the action of leukotrienes, these agents effectively reduce inflammation and alleviate respiratory symptoms. Their use as part of a comprehensive treatment approach can significantly improve the quality of life for patients suffering from asthma and other related respiratory disorders.
Zafirlukast (Leukotriene antagonists), classified under Respiratory Tract Agents
Respiratory Tract Agents are a vital category of pharmaceutical APIs (Active Pharmaceutical Ingredients) designed to treat respiratory conditions and diseases. These agents are specifically formulated to target the respiratory system, which includes the lungs, airways, and nasal passages. They play a crucial role in managing various respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.
Respiratory Tract Agents encompass a wide range of medications, including bronchodilators, corticosteroids, antihistamines, and mucolytics. Bronchodilators are commonly used to relieve airway constriction and facilitate smooth breathing by relaxing the muscles in the airways. Corticosteroids help reduce inflammation in the respiratory system, alleviating symptoms and preventing exacerbations. Antihistamines work by blocking histamine receptors, thus mitigating allergic reactions that often impact the respiratory tract. Mucolytics aid in loosening and thinning mucus, making it easier to expel from the airways.
These APIs are developed through rigorous research and development processes, ensuring their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers rely on advanced technologies and stringent quality control measures to produce high-quality Respiratory Tract Agents. These APIs are subsequently incorporated into various dosage forms, including inhalers, nasal sprays, nebulizers, and oral medications.
Respiratory Tract Agents are essential in the management of respiratory conditions, providing relief from symptoms, improving lung function, and enhancing the overall quality of life for patients. They are prescribed by healthcare professionals and often used in combination therapies to achieve optimal results. As respiratory disorders continue to affect a significant portion of the global population, the development and availability of effective Respiratory Tract Agents play a vital role in addressing these health challenges and improving patient outcomes.
Zafirlukast manufacturers | traders | suppliers
We have 3 companies offering Zafirlukast produced in 1 different countries.
Get in contact with the supplier of your choice:
- Chromo Labs. from India, product country of origin India
- Dr. Reddy's from India, product country of origin India
- Hetero Drugs from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
